Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study

BACKGROUND: Several biomarkers have been established for metastatic colorectal cancer (mCRC). We investigated whether plasma angiogenesis factors could predict the efficacy of biologics combined with chemotherapy in first‐line (1L) treatment in patients with RAS wild‐type mCRC and the dynamics of pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuki, Satoshi, Yamazaki, Kentaro, Sunakawa, Yu, Taniguchi, Hiroya, Bando, Hideaki, Shiozawa, Manabu, Nishina, Tomohiro, Yasui, Hisateru, Kagawa, Yoshinori, Takahashi, Naoki, Denda, Tadamichi, Esaki, Taito, Kawakami, Hisato, Satake, Hironaga, Takashima, Atsuo, Matsuhashi, Nobuhisa, Kato, Takeshi, Asano, Chiharu, Abe, Yukiko, Nomura, Shogo, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557901/
https://www.ncbi.nlm.nih.gov/pubmed/37641470
http://dx.doi.org/10.1002/cam4.6486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557901/
https://www.ncbi.nlm.nih.gov/pubmed/37641470
http://dx.doi.org/10.1002/cam4.6486

Ejemplares similares